
|Videos|November 5, 2021
The Role of Potassium-Binding Agents in Treating Hyperkalemia
Dr. Cary Boyd-Shiwarski explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.
Advertisement
Pharmacy Times spoke to Dr. Cary Boyd-Shiwarski about her session at the ASN 2021 conference titled "Mechanisms of Potassium Handling in CKD."
Boyd explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Orforglipron Reduces Body Weight Up to 14% in Women at Every Stage of Menopause
2
New Evidence Positions Finerenone as Foundational Therapy Across the CKD Spectrum
3
OTC Guide: Thirty Years Strong
4
EPCORE DLBCL-1 Trial Demonstrates Durable Responses, PFS Benefit With Epcoritamab in RR LBCL
5






























































































































